News
HC Wainwright & Co. Reiterates Buy on Precision BioSciences, Maintains $60 Price Target
17 Apr 24
News, Price Target, Reiteration, Analyst Ratings
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
17 Apr 24
Movers
Precision BioSciences Announces Return Of Programs And Conclusion Of Collaboration With Prevail Therapeutics
16 Apr 24
Biotech, News, General
iECURE Announces FDA Clearance Of IND Application For ECUR-506 To Initiate OTC-HOPE Trial For Treatment Of Neonatal Onset Ornithine Transcarbamylase Deficiency In The U.S.; NOTE: iECURE Has Licensed The ARCUS Nuclease For ECUR-506 From Precision BioSciences
4 Apr 24
Biotech, News, FDA, General
Precision BioSciences Q4 GAAP EPS $(4.06) May Not Be Comparable To $(2.05) Estimate, Sales $7.04M Miss $12.48M Estimate
27 Mar 24
Earnings, News
Earnings Scheduled For March 27, 2024
27 Mar 24
Earnings
Earnings Preview: Precision BioSciences
26 Mar 24
Earnings
Why Zscaler Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
1 Mar 24
News, Penny Stocks, Small Cap, Intraday Update, Markets, Movers, Trading Ideas
12 Health Care Stocks Moving In Friday's Intraday Session
1 Mar 24
Movers
12 Health Care Stocks Moving In Friday's Pre-Market Session
1 Mar 24
Movers
12 Health Care Stocks Moving In Thursday's After-Market Session
29 Feb 24
Movers
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
27 Feb 24
Movers
HC Wainwright & Co. Reiterates Buy on Precision BioSciences, Maintains $3 Price Target
14 Feb 24
News, Price Target, Reiteration, Analyst Ratings
Precision BioSciences Receives Pre-IND Feedback From FDA For PBGENE-HBV As It Advances Towards Clinical Readiness
14 Feb 24
Biotech, News, Health Care, FDA, General
Precision Biosciences Received An Initial $7.5M Upfront Cash Payment And Equity Investment From TG Therapeutics For An Exclusive License To Develop Azercabtagene Zapreleucel For Autoimmune Diseases And Other Indications Outside Of Cancer
12 Feb 24
Biotech, News, Health Care, Financing, Contracts, General
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
30 Jan 24
Movers
Press releases
Precision BioSciences Announces Return of Programs and Conclusion of Collaboration with Prevail Therapeutics
16 Apr 24
Press Releases
iECURE Announces FDA Clearance of Investigational New Drug Application for ECUR-506 to Initiate OTC-HOPE Trial for Treatment of Neonatal Onset Ornithine Transcarbamylase Deficiency in the U.S.
4 Apr 24
Press Releases
Precision BioSciences Reports Fourth Quarter and Fiscal Year 2023 Financial Results and Provides Business Update
27 Mar 24
Press Releases
Precision BioSciences to Report Fourth Quarter and Fiscal Year 2023 Results on March 27, 2024
20 Mar 24
Press Releases
Precision BioSciences Announces MHRA Approval for Partner iECURE to Expand Phase 1/2 Clinical Trial of ARCUS Gene Editing Program in OTC Deficiency
6 Mar 24
Press Releases
Precision BioSciences Announces $40.0 Million Offering of Common Stock and Warrants
1 Mar 24
Press Releases
Precision BioSciences Announces Proposed Public Offering of Common Stock and Warrants
29 Feb 24
Press Releases
Precision BioSciences Receives Pre-IND Feedback from US FDA for PBGENE-HBV as it Advances Towards Clinical Readiness
14 Feb 24
Press Releases
Precision BioSciences Promotes Naresh Tanna to Vice President of Investor Relations
13 Feb 24
Press Releases
Precision BioSciences Receives Initial $7.5 Million Cash Payment and Equity Investment from TG Therapeutics for Azel-Cel in Treatment of Autoimmune Diseases
12 Feb 24
Press Releases
Precision BioSciences to Effect a Reverse Stock Split
9 Feb 24
Press Releases